Marksans Pharma Limited has informed the Exchange regarding a press release dated May 30, 2025, titled ""Marksans Pharma Limited s wholly owned subsidiary in UK, Relonchem Limited receives Marketing Authorization for the product Metformin Hydrochloride 500 mg/ 5ml Oral Solution."".